deltatrials
Recruiting NA INTERVENTIONAL 2-arm NCT05149196

Goal-directed Hemodynamic Management and Kidney Injury After Radical Nephrectomy or Nephroureterectomy

Impact of Goal-directed Hemodynamic Management on Occurrence of Acute and Persistent Kidney Injury After Radical Nephrectomy or Nephroureterectomy: A Randomized Controlled Trial

Sponsor: Peking University First Hospital

Updated 7 times since 2022 Last updated: Jun 2, 2025 Started: Feb 10, 2025 Primary completion: Dec 30, 2032 Completion: Dec 30, 2034
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05149196, this NA trial focuses on Acute Kidney Injury and Chronic Kidney Diseases and remains actively recruiting participants. Sponsored by Peking University First Hospital, it has been updated 7 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2022 – ~May 2022 · 4 months · monthly snapshotNot Yet Recruiting~May 2022 – ~Jul 2024 · 26 months · monthly snapshotNot Yet Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotNot Yet Recruiting~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshotNot Yet Recruiting~Oct 2024 – ~Nov 2024 · 31 days · monthly snapshotNot Yet Recruiting~Nov 2024 – ~Jun 2025 · 7 months · monthly snapshotNot Yet Recruiting~Jun 2025 – present · 13 months · monthly snapshotRecruiting

Change History

7 versions recorded
  1. Jun 2025 — Present [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  2. Nov 2024 — Jun 2025 [monthly]

    Not Yet Recruiting NA

  3. Oct 2024 — Nov 2024 [monthly]

    Not Yet Recruiting NA

  4. Sep 2024 — Oct 2024 [monthly]

    Not Yet Recruiting NA

  5. Jul 2024 — Sep 2024 [monthly]

    Not Yet Recruiting NA

Show 2 earlier versions
  1. May 2022 — Jul 2024 [monthly]

    Not Yet Recruiting NA

  2. Jan 2022 — May 2022 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Peking University First Hospital
Data source: Peking University First Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations